FDA Could Soon OK First Weight Loss Drug in a Decade San Diego Business Journal He estimated that peak US sales for Vivus' Qnexa will reach $900 million, compared with $700 million for Orexigen's Contrave and $400 million for Arena's ... See all stories on this topic |
Investing in the Obesity Drug Basket Seeking Alpha (blog) Orexigen's Contrave is a combination of two generic drugs, bupropion and naltrexone. Bupropion is an antidepressant formerly marketed as Wellbutrin. ... See all stories on this topic |
Options Update: Prexogem (OREX), American Int'l (AIG) & CBOE ... The Options Insider orex's Contrave has showed strong results in three large late stage studies in treating obesity. OREX call option volume of 2708 contracts compares to put ... See all stories on this topic |
YOU CAN GET THE BODDY YOU WANT
TAGS:Weigh, waight , wieght. Weigth, weigt, rapid weight loss, loose weight,
weightloss